Viking Therapeutics (VKTX) Current Leases: 2019-2025
Historic Current Leases for Viking Therapeutics (VKTX) over the last 7 years, with Sep 2025 value amounting to $437,000.
- Viking Therapeutics' Current Leases fell 8.96% to $437,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $437,000, marking a year-over-year decrease of 8.96%. This contributed to the annual value of $489,000 for FY2024, which is 50.93% up from last year.
- According to the latest figures from Q3 2025, Viking Therapeutics' Current Leases is $437,000, which was down 6.62% from $468,000 recorded in Q2 2025.
- In the past 5 years, Viking Therapeutics' Current Leases ranged from a high of $498,000 in Q1 2025 and a low of $29,000 during Q4 2021.
- Moreover, its 3-year median value for Current Leases was $334,000 (2024), whereas its average is $391,000.
- In the last 5 years, Viking Therapeutics' Current Leases plummeted by 91.21% in 2021 and then spiked by 948.28% in 2022.
- Viking Therapeutics' Current Leases (Quarterly) stood at $29,000 in 2021, then spiked by 948.28% to $304,000 in 2022, then climbed by 6.58% to $324,000 in 2023, then soared by 50.93% to $489,000 in 2024, then declined by 8.96% to $437,000 in 2025.
- Its Current Leases was $437,000 in Q3 2025, compared to $468,000 in Q2 2025 and $498,000 in Q1 2025.